Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.

Jambor I, Falagario U, Ratnani P, Perez IM, Demir K, Merisaari H, Sobotka S, Haines GK, Martini A, Beksac AT, Lewis S, Pahikkala T, Wiklund P, Nair S, Tewari A.

J Magn Reson Imaging. 2019 Sep 30. doi: 10.1002/jmri.26928. [Epub ahead of print]

PMID:
31566845
2.

Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.

Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC.

Actas Urol Esp. 2014 Jun;38(5):290-7. doi: 10.1016/j.acuro.2013.11.003. Epub 2014 Jan 1. English, Spanish.

PMID:
24387827
3.

Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.

Gaur S, Harmon S, Mehralivand S, Bednarova S, Calio BP, Sugano D, Sidana A, Merino MJ, Pinto PA, Wood BJ, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2018 Nov;48(5):1326-1335. doi: 10.1002/jmri.26025. Epub 2018 Mar 31.

4.

Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.

Chung DY, Koh DH, Goh HJ, Kim MS, Lee JS, Jang WS, Choi YD.

BMC Cancer. 2018 Nov 1;18(1):1057. doi: 10.1186/s12885-018-4955-8.

5.

All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map.

Greer MD, Shih JH, Barrett T, Bednarova S, Kabakus I, Law YM, Shebel H, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2018 Aug;48(2):482-490. doi: 10.1002/jmri.25948. Epub 2018 Jan 17.

PMID:
29341356
6.

Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.

Gondo T, Hricak H, Sala E, Zheng J, Moskowitz CS, Bernstein M, Eastham JA, Vargas HA.

Eur Radiol. 2014 Dec;24(12):3161-70. doi: 10.1007/s00330-014-3367-7. Epub 2014 Aug 7.

PMID:
25100337
7.

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA.

De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G.

Clin Radiol. 2017 Jan;72(1):23-32. doi: 10.1016/j.crad.2016.09.011. Epub 2016 Oct 7.

PMID:
27726850
8.

Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.

Dwivedi DK, Kumar R, Dwivedi AK, Bora GS, Thulkar S, Sharma S, Gupta SD, Jagannathan NR.

J Magn Reson Imaging. 2018 May;47(5):1227-1236. doi: 10.1002/jmri.25850. Epub 2017 Sep 4.

PMID:
28872226
10.

Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.

Martini A, Gupta A, Lewis SC, Cumarasamy S, Haines KG 3rd, Briganti A, Montorsi F, Tewari AK.

BJU Int. 2018 Dec;122(6):1025-1033. doi: 10.1111/bju.14353. Epub 2018 May 14.

11.

A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).

Gaur S, Harmon S, Gupta RT, Margolis DJ, Lay N, Mehralivand S, Merino MJ, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

Acad Radiol. 2019 Jan;26(1):5-14. doi: 10.1016/j.acra.2018.03.024. Epub 2018 Apr 25.

12.

Intra- and interreader reproducibility of PI-RADSv2: A multireader study.

Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, An JY, Czarniecki M, Mehralivand S, Coskun M, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2019 Jun;49(6):1694-1703. doi: 10.1002/jmri.26555. Epub 2018 Dec 21.

PMID:
30575184
13.

Multiparametric MRI in detection and staging of prostate cancer.

Boesen L.

Dan Med J. 2017 Feb;64(2). pii: B5327. Review.

PMID:
28157066
14.

Central zone lesions on magnetic resonance imaging: Should we be concerned?

Tan WP, Mazzone A, Shors S, Antoine N, Ekbal S, Khare N, McKiel C, Pessis D, Deane L.

Urol Oncol. 2017 Jan;35(1):31.e7-31.e12. doi: 10.1016/j.urolonc.2016.08.006. Epub 2016 Sep 28.

PMID:
27692837
15.

Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.

Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M.

Brachytherapy. 2017 Nov - Dec;16(6):1106-1112. doi: 10.1016/j.brachy.2017.07.008. Epub 2017 Aug 12.

PMID:
28807747
16.

Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.

Choi MH, Kim CK, Lee YJ, Jung SE.

AJR Am J Roentgenol. 2019 Apr;212(4):839-846. doi: 10.2214/AJR.18.20498. Epub 2019 Feb 19.

PMID:
30779662
17.

Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.

Park JJ, Kim CK, Park SY, Park BK, Lee HM, Cho SW.

AJR Am J Roentgenol. 2014 May;202(5):W459-65. doi: 10.2214/AJR.13.11381.

PMID:
24758681
18.

Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.

Park SY, Oh YT, Jung DC, Cho NH, Choi YD, Rha KH, Hong SJ.

Eur Radiol. 2016 Aug;26(8):2502-9. doi: 10.1007/s00330-015-4077-5. Epub 2015 Nov 11.

PMID:
26560721
19.

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.

Montoya Perez I, Jambor I, Pahikkala T, Airola A, Merisaari H, Saunavaara J, Alinezhad S, Väänänen RM, Tallgrén T, Verho J, Kiviniemi A, Ettala O, Knaapila J, Syvänen KT, Kallajoki M, Vainio P, Aronen HJ, Pettersson K, Boström PJ, Taimen P.

J Magn Reson Imaging. 2019 Oct 6. doi: 10.1002/jmri.26945. [Epub ahead of print]

PMID:
31588660
20.

Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.

Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ.

Eur Urol. 2018 Jun;73(6):879-887. doi: 10.1016/j.eururo.2017.11.012. Epub 2017 Nov 28.

PMID:
29195777

Supplemental Content

Support Center